This page contains a Flash digital edition of a book.
SETTING Presenter: Ruth Carrico, PhD, RN, CIC ACUTE CARE


Carbapenem-Resistant Enterobacteriaceae Carbapenem-Resistant Enterobacteriaceae are emerging multi-drug resistant organisms in healthcare set- tings. Infections caused by these pathogens are associated with high morbidity and mortality. Fortunately, though they are being encountered more commonly, they are not yet endemic in most of the U.S. This webinar reviews the current epidemiology and microbiology of these pathogens and will discuss recent CDC infection control recommendations targeted at Carbapenem-Resistant Enterobacteriaceae.


Presenter: Arjun Srinivasan, MD ALL SETTINGS


MDR Gram-Negative Rods: Whats Here and What’s Coming MDR gram-negative rods (MDR-GNRs) are an ever-increasing challenge for infection preventionists. These organisms can cause serious invasive infections and have few or no treatment options. This presentation reviews the key gram-negative pathogens that have shown increasing resistance to strategies for control- ling their spread. The role of surveillance for MDR-GNR is discussed, and data from the National Healthcare Safety Network demonstrating overall trends in merging and increasing resistance is presented. The detec- tion and control of newly identified metallo beta-lactamase-producing Enterobacteriaceae, NDM-1, is also discussed.


Presenter: Taranisia MacCannell, MSc, PhD PEDIATRICS


Outbreak of Multidrug-Resistant Acinetobacter Baumannii Colonization in a Neonatal Intensive Care Unit


Published accounts of Acinetobacter outbreaks in neonatal ICUs are rare, particularly in the U.S. This presen- tation provides an overview of an outbreak of multidrug-resistant Acinetobacter baumannii (MDR-Ab) in a


24


WEBINARS


ists and healthcare personnel are familiar with modes of transmission, specific prevention activities, and response to increased incidence of disease. This webinar will explore the changing pathogenesis of this infection and will provide basic and more advanced infection prevention responses.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31